Skip to main content

Aberdeen Group plc

Position in DNLI — Denali Therapeutics Inc.

CIK 1716774 EDINBURGH, X0

Position in DNLI

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$34,605,771
-$999,592 QoQ
Shares Held
1,345,481
-27.4% QoQ
Ownership
0.842%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#30
of 290 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. DNLI ranks #14 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,605,771 1,345,481
2026-03-31 $35,605,363 1,854,446
2025-12-31 $33,564,285 2,032,967
2025-09-30 $16,169,268 1,113,586
2025-06-30 $12,629,486 902,751
2025-03-31 $10,329,684 759,815
2024-12-31 $8,198,507 402,282
2024-09-30 $10,593,969 363,679
2024-06-30 $13,305,872 573,035
2024-03-31 $10,588,709 516,019
2023-12-31 $6,970,830 324,829